ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 38 filers reported holding ONCTERNAL THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,000 | +73.9% | 10,000 | +100.0% | 0.00% | – |
Q2 2023 | $1,725 | -56.1% | 5,000 | 0.0% | 0.00% | – |
Q1 2023 | $3,925 | -21.5% | 5,000 | 0.0% | 0.00% | – |
Q4 2022 | $5,000 | +25.0% | 5,000 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | -33.3% | 5,000 | 0.0% | 0.00% | -100.0% |
Q2 2022 | $6,000 | -14.3% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $7,000 | -36.4% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $11,000 | -47.6% | 5,000 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $21,000 | -12.5% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $24,000 | -42.9% | 5,000 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $42,000 | +75.0% | 5,000 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $24,000 | +242.9% | 5,000 | +25.0% | 0.00% | +100.0% |
Q3 2020 | $7,000 | -36.4% | 4,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $11,000 | -8.3% | 4,000 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $12,000 | -36.8% | 4,000 | -18.4% | 0.00% | 0.0% |
Q4 2019 | $19,000 | -20.8% | 4,900 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $24,000 | – | 4,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,501,000 | 0.78% |
Parkman Healthcare Partners LLC | 325,384 | $1,357,000 | 0.34% |
Vigilare Wealth Management | 63,460 | $265,000 | 0.16% |
BRIGHTON JONES LLC | 333,875 | $1,392,000 | 0.07% |
HighVista Strategies LLC | 23,121 | $97,000 | 0.06% |
Ikarian Capital, LLC | 199,180 | $830,000 | 0.06% |
Total Clarity Wealth Management, Inc. | 26,430 | $110,000 | 0.05% |
IPG Investment Advisors LLC | 30,756 | $128,253,000 | 0.04% |
DOWLING & YAHNKE LLC | 150,464 | $627,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 22,015 | $92,000 | 0.01% |